PubMed Health⌕ Search

Biomedical subjects

David Gardner

Publications and source records attributed to David Gardner.

5 recordsLinked to original sources
PubMed2006

Lipid management reduces cardiovascular complications in individuals with diabetes and prediabetes.

Patients with type 2 diabetes are known to have an elevated risk of cardiovascular morbidity and mortality. Prior to the development of hyperglycemia and type 2 diabetes, individuals undergo a prolonged prediabetic phase involving hyperglycemia and insulin resistance. This has been associated with increased cardiovascular risk and is considered a cardiovascular risk equivalent. It is well known that dyslipidemia is an important contributor to the development of coronary artery disease. Treating diabetes with lipid-lowering agents reduces patients' cardiovascular risk. Preliminary studies have shown that similar benefits are seen even in persons with prediabetes. Hence, lipid-lowering agents should be considered not only in patients with type 2 diabetes, but also in individuals with prediabetes and with elevated lipid levels.

Blood Glucose↗
PubMedDate not supplied

The etiology of obesity.

The worldwide increase in the prevalence of obesity, and the dire health consequences of this increase, has been well-documented. In this review of obesity, we will examine possible mechanisms for this increase and what the implications are for prevention and treatment of this vital public health problem.

Energy Metabolism↗